- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Nivolumab and ipilimumab – March 2017
Nivolumab and Ipilimumab: Nivolumab: Opdivo® and Ipilimumab: Yervoy®
Last updated
30 June 2017